Kessing, LV, Hansen, MG, Andersen, PK. Course of illness in depressive and bipolar
disorders. Naturalistic study, 1994–1999. Br J
2004; 185: 372–7.
Tohen, M, Hennen, J, Zarate, CM Jr, Baldessarini, RJ, Strakowski, SM, Stoll, AL, et al. Two-year syndromal and functional recovery in
219 cases of first-episode major affective disorder with psychotic
features. Am J Psychiatry
2000; 157: 220–8.
Bourne, C, Aydemir, O, Balanza-Martinez, V, Bora, E, Brissos, S, Cavanagh, JT, et al. Neuropsychological testing of cognitive
impairment in euthymic bipolar disorder: an individual patient data
meta-analysis. Acta Psychiatr Scand
2013; 128: 149–62.
Kessing, LV, Nilsson, FM. Increased risk of developing dementia in patients
with major affective disorders compared to patients with other medical
illnesses. J Affect Disord
2003; 73: 261–9.
Berk, M, Berk, L, Dodd, S, Cotton, S, Macneil, C, Daglas, R, et al. Stage managing bipolar
disorder. In Bipolar Disord
Goodwin, GM, Geddes, JR. Latest maintenance data on lithium in bipolar
disorder. Eur Neuropsychopharmacol
2003; 13 (suppl 2):
Coryell, W. Maintenance treatment in bipolar disorder: a
reassessment of lithium as the first choice.
2009; 11 (suppl 2):
Gray, JD, McEwen, BS. Lithium's role in neural plasticity and its
implications for mood disorders. Acta Psychiatr
2013; 128: 347–61.
Grunze, H, Vieta, E, Goodwin, GM, Bowden, C, Licht, RW, Möller, HJ, et al. The World Federation of Societies of
Biological Psychiatry (WFSBP) guidelines for the biological treatment of
bipolar disorders: update 2012 on the long-term treatment of bipolar
disorder. World J Biol Psychiatry
Kessing, LV, Hansen, HV, Christensen, EM, Dam, H, Gluud, C, Wettersley, J. Do young adults with bipolar disorder benefit from
J Affect Disord
2014; 152–154: 403–8.
Kleindienst, N, Engel, R, Greil, W. Which clinical factors predict response to
prophylactic lithium? A systematic review for bipolar
disorders. Bipolar Disord
2005; 7: 404–17.
Kessing, LV, Hellmund, G, Andersen, PK. Predictors of excellent response to lithium: results
from a nationwide register-based study. Int Clin
2011; 26: 323–8.
Sachs, GS, Printz, DJ, Kahn, OA, Carpenter, D, Docherty, JP. The Expert Consensus Guideline Series: Medication
Treatment of Bipolar Disorder 2000. In Postgrad
Licht, RW, Vestergaard, P, Kessing, LV, Larsen, JK, Thomsen, PH. Psychopharmacological treatment with lithium and
antiepileptic drugs: suggested guidelines from the Danish Psychiatric
Association and the Child and Adolescent Psychiatric Association in
Denmark. Acta Psychiatr Scand Suppl
Nolen, WA, Kupka, RW, Schulte, PFJ, Knoppert-van der Klein, EAM, Honig, A, et al. Richtlijn Bipolaire Stoornissen
(2nd edn) . UtrechtL De Tijdstrom uitgerverij
Yatham, LN, Kennedy, SH, Parikh, SV, Schaffer, A, Beaulieu, S, Alda, M, et al. Canadian Network for Mood and Anxiety
Treatments (CANMAT) and International Society for Bipolar Disorders
(ISBD) collaborative update of CANMAT guidelines for the management of
patients with bipolar disorder: update 2013.
Goodwin, GM. Evidence-based guidelines for treating bipolar
disorder: revised second edition – recommendations from the British
Association for Psychopharmacology. J
2009; 23: 346–88.
Munk-Jorgensen, P, Mortensen, PB. The Danish Psychiatric Central
Register. Dan Med Bull
1997; 44: 82–4.
Danish Health and Medicines Authority. Medicinal
Product Statistics. Danish Health and Medicines
Authority, 2002 (http://sundhedsstyrelsen.dk).
Juel, K, Helweg-Larsen, K. The Danish registers of causes of
death. Dan Med Bull
1999; 46: 354–7.
Andersen, TF, Madsen, M, Jorgensen, J, Mellemkjaer, L, Olsen, JH. The Danish National Hospital Register. A valuable
source of data for modern health sciences. Dan
1999; 46: 263–8.
World Health Organization. Klassifikation af
Sygdomme Systematisk del International Statistical [Classification of
Diseases and Health Related Problems, Tenth Revision] (Danish
WHO Collaborating Centre for Drug Statistics Methodology.
ATC index with DDDs. WHO Collaborating
Centre for Drug Statistics Methodology,
Kessing, LV, Andersen, PK, Mortensen, PB. Predictors of recurrence in affective disorder. A
case register study. J Affect Disord
1998; 49: 101–8.
Kessing, LV, Sondergard, L, Kvist, K, Andersen, PK. Adherence to lithium in naturalistic settings:
results from a nationwide pharmacoepidemiological study.
2007; 9: 730–6.
Kessing, LV. The effect of comorbid alcoholism on recurrence in
affective disorder: a case register study. J
Farren, CK, Hill, KP, Weiss, RD. Bipolar disorder and alcohol use disorder: a
review. Curr Psychiatry Rep
2012; 14: 659–66.
Kulhara, P, Basu, D, Mattoo, SK, Sharan, P, Chopra, R. Lithium prophylaxis of recurrent bipolar affective
disorder: long-term outcome and its psychosocial
correlates. J Affect Disord
Berghofer, A, Alda, M, Adli, M, Baethge, C, Bauer, M, Bschor, T, et al. Long-term effectiveness of lithium in bipolar
disorder: a multicenter investigation of patients with typical and
atypical features. J Clin Psychiatry
2008; 69: 1860–8.
Pfennig, A, Schlattmann, P, Alda, M, Grof, P, Glenn, T, Müller-Oerlinghausen, B, et al. Influence of atypical features on the quality
of prophylactic effectiveness of long-term lithium treatment in bipolar
disorders. Bipolar Disord
2010; 12: 390–6.
Maj, M, Pirozzi, R, Magliano, L, Bartoli, L. Long-term outcome of lithium prophylaxis in bipolar
disorder: a 5-year prospective study of 402 patients at a lithium
clinic. Am J Psychiatry
1998; 155: 30–5.
Calabrese, JR, Rapport, DJ, Youngstrom, EA, Jackson, K, Bilali, S, Findling, RL. New data on the use of lithium, divalproate, and
lamotrigine in rapid cycling bipolar disorder.
2005; 20: 92–5.
Fountoulakis, KN, Kontis, D, Gonda, X, Yatham, LN. A systematic review of the evidence on the treatment
of rapid cycling bipolar disorder. Bipolar
2013; 15: 115–37.
Kessing, LV. Diagnostic stability in bipolar disorder in clinical
practise as according to ICD-10. J Affect
2005; 85: 293–99.
Perugi, G, Micheli, C, Akiskal, HS, Madaro, D, Socci, C, Quilici, C, et al. Polarity of the first episode, clinical
characteristics, and course of manic depressive illness: a systematic
retrospective investigation of 320 bipolar I patients.
2000; 41: 13–8.
Geddes, JR, Goodwin, GM, Rendell, J, Azorin, JM, Cipriani, A, Ostacher, MJ, et al. Lithium plus valproate combination therapy
versus monotherapy for relapse prevention in bipolar I disorder
(BALANCE): a randomised open-label trial.
2010; 375: 385–95.
Kessing, LV, Hellmund, G, Geddes, JR, Goodwin, GM, Andersen, PK.
Valproate v. lithium in the treatment of bipolar
disorder in clinical practice: observational nationwide register-based
cohort study. Br J Psychiatry
Kessing, LV, Hellmund, G, Andersen, PK. An observational nationwide register based cohort
study on lamotrigine versus lithium in bipolar disorder.
2012; 26: 644–52.
Malhi, GS. The king is dead, long live the king! The
restoration of BALANCE. Bipolar Disord
2010; 12: 681–4.
Ghaemi, SN. From BALANCE to DSM-5: taking lithium
seriously. Bipolar Disord
2010; 12: 673–7.
Pfennig, A, Bschor, T, Falkai, P, Bauer, M. The diagnosis and treatment of bipolar disorder:
recommendations from the current s3 guideline.
Dtsch Arztebl Int